Skip to content
★ Sign in to follow
JF

J Ford

Compliance
Total declarations
17
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 20 Jul 2023 for GSK plc, €7,488.

Filing timeline

BuySale
J Ford

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

  • GSK plc 5 purchases · last 20 Jul 2023

J Ford: trading record in brief

All filings by J Ford on record concern GSK plc. Between 9 August 2022 and 18 July 2023, the trades on record add up to 17 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 20 July 2023 came the latest disclosure, a share grant in GSK plc. Typically, a trade is published a median of 3 days after it takes place. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to J Ford

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ◆
    SVP and Group General Counsel, Legal and ComplianceExecutivesGSK plc
    6,437 GBP19RNS
    484 shares@ £13.3091.9% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4842360-3
  • ▲
    SVP and Group General Counsel, Legal and ComplianceExecutivesGSK plc
    0RNS
    0London Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4842360-15
    Canonical exit: 16 Oct 2023 (T+90)
  • ▲
    SVP and Group General Counsel, Legal and ComplianceExecutivesGSK plc
    0RNS
    0New York Stock Exchange (XNYS)ISIN US37733W2044RNS:4842360-26
    Canonical exit: 16 Oct 2023 (T+90)
  • ▲
    SVP and Group General Counsel, Legal and ComplianceExecutivesGSK plc
    80 GBP29RNS
    6 shares@ £13.35331.2% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4837969-2
    Canonical exit: 11 Oct 2023 (T+90)
  • ▲
    SVP and Group General Counsel, Legal and ComplianceExecutivesGSK plc
    235 GBP29RNS
    18 shares@ £13.06723.4% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4835002-1
    Canonical exit: 9 Oct 2023 (T+90)
  • ▲
    SVP and Group General Counsel, Legal and ComplianceExecutivesGSK plc
    248 GBP29RNS
    18 shares@ £13.79673.6% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4799763-1
    Canonical exit: 7 Sept 2023 (T+90)

6 of 6 declarations